Latest Escitalopram Stories
Company Provides Fiscal Year 2010 EPS Guidance in the Range of $3.45-$3.55 Per Share NEW YORK, April 21 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc.
NEW YORK, March 20, 2009 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc. (NYSE: FRX) today announced that the U.S.
NEW YORK, Feb. 26, 2009 /PRNewswire-FirstCall/ --Forest Laboratories, Inc.
U.S. authorities accused a New York pharmaceutical company Wednesday of making false claims about two antidepressants it markets for unapproved pediatric use. The civil complaint unsealed in U.S. District Court in Massachusetts, not only alleges Forest Laboratories Inc.
Pharmaceutical Company Allegedly Marketed Drugs for Unapproved Pediatric Use and Paid Kickbacks WASHINGTON, Feb. 25 /PRNewswire-USNewswire/ -- A Complaint was unsealed today in U.S.
Researchers have concluded that Pfizer Incâ€™s Zoloft and Forrest Laboratories Incâ€™s Lexapro are superior antidepressant drugs compared to 12 other new drugs in their class.
US researchers announced on Tuesday that the antidepressant Lexapro seemed to ease anxiety in older adults, but the outcome is "modest" and requires further investigation.
Q. Last night, my boyfriend became so violent, I was afraid he was going to hit my 22-year-old daughter or me. He threatened to burn down our home, and he tried to kick me out. I just realized that he started changing in the past two weeks right after he started taking Chantix to quit smoking.
Adheris, Inc., a leader in patient adherence and education programs, announced today the results of a new study that examined adherence rates among patients on SSRI/SNRI antidepressant therapy.
Lundbeck has announced that the FDA has completed the initial check for completeness and accepted the new drug application on Serdolect for the treatment of schizophrenia for review.
- Large; stout; burly.